Skip to main content

Missoula Agrees To Join Opioid Lawsuit Against Drug Makers

Missoula Agrees To Join Opioid Lawsuit Against Drug Makers

Missoula Agrees To Join Opioid Lawsuit Against Drug Makers

Introduction

A Missoula City Council committee agreed to join the opioid lawsuit filed by other governments in Montana, including Great Falls and Lake County, against the manufacturers and distributors of prescription opioids.

Mayor John Engen said, "what this retention agreement allows us to do is to pursue some of those damages and receive direct benefit from the suit rather than joining the Montana attorney general, for example, and being in a position of sharing that pot of money in a way that’s largely out of our control.” According to a report from the U.S. Centers for Disease Control and Prevention, the opioid litigation costs about  $55.7 billion annually. About 45% is assigned to health-care costs, 9% is allocated to criminal justice costs, and 46% goes to workplace costs, such as productivity loss. The multidistrict litigation (MDL) would be transferred to a federal court in Ohio where it would be handled by a law firm there, Simon Greenstone Panatier.

More than 1,600 opioid lawsuits filed by opioid affected individuals are consolidated into a multidistrict litigation MDL No. 2804 (In Re: National Prescription Opiate Litigation) overlooked by Judge Polster in the Northern District of Ohio. The first bellwether trial in the litigation has been set for September 2019, involving lawsuits filed by Cleveland and the Ohio counties of Cuyahoga and Summit.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!